AliveCor announced today that it received FDA clearance for the next generation of its AI technology for the Kardia 12L ECG ...
Medical Device Network on MSN
AliveCor secures FDA approval for next-generation Kardia 12L ECG system
The newly cleared features include three rhythm modifiers and two axis-related morphology determinations: RAD and LAD.
While AliveCore faced two wins, the dispute did not end there. In March 2025, Apple triumphed in a major patent dispute with ...
MOUNTAIN VIEW, Calif., Nov. 12, 2018 /PRNewswire/ -- AliveCor, the leader in FDA-cleared personal electrocardiogram (ECG) technology, has announced that a research version of its mobile technology can ...
AliveCor, the global leader in AI-powered cardiology, today announced it has received U.S. Food and Drug Administration (FDA) ...
Please provide your email address to receive an email when new articles are posted on . AliveCor announced the FDA clearance and launch of its AI for ECG interpretation and streamlined, handheld ECG ...
MOUNTAIN VIEW, Calif., Jan. 16, 2025 /PRNewswire/ -- AliveCor, the leading innovator in FDA-cleared personal electrocardiogram (ECG) technology, today announced that the Centers for Medicare & ...
Powered by AliveCor's proprietary KAI 12L AI technology, the pocket-sized Kardia 12L ECG System was designed exclusively for healthcare settings to detect 35 cardiac determinations, including heart ...
Smartphone-connected ECG maker AliveCor has added a telemedicine service to its product. AliveCor AliveInsights will allow patients to send their recorded ECG readings to remote cardiac technicians or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback